iBio Inc [IBIO] stock prices are up 0.53% to $0.85 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The IBIO shares have gain 7.42% over the last week, with a monthly amount drifted -2.30%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
iBio Inc [NASDAQ: IBIO] stock has seen the most recent analyst activity on October 17, 2025, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $2. Previously, Chardan Capital Markets started tracking the stock with Buy rating on May 28, 2024, and set its price target to $5. On November 29, 2021, JMP Securities initiated with a Mkt Outperform rating and assigned a price target of $1.50 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $3 on January 22, 2021. Alliance Global Partners initiated its recommendation with a Buy and recommended $2.55 as its price target on June 26, 2020.
The stock price of iBio Inc [IBIO] has been fluctuating between $0.56 and $6.89 over the past year. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. iBio Inc [NASDAQ: IBIO] shares were valued at $0.85 at the most recent close of the market. An investor can expect a potential return of 135.29% based on the average IBIO price forecast.
Analyzing the IBIO fundamentals
The iBio Inc [NASDAQ:IBIO] reported sales of 0.40M for trailing twelve months, representing a surge of 14.29%. Gross Profit Margin for this corporation currently stands at 2.98% with Operating Profit Margin at -44.83%, Pretax Profit Margin comes in at -43.89%, and Net Profit Margin reading is -55.98%. To continue investigating profitability, this company’s Return on Assets is posted at -1.1, Equity is -1.3 and Total Capital is -1.23. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.26.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.8241 points at the first support level, and at 0.7983 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.8929, and for the 2nd resistance point, it is at 0.9359.
Ratios To Look Out For
It’s worth pointing out that iBio Inc [NASDAQ:IBIO]’s Current Ratio is 1.59. As well, the Quick Ratio is 1.59, while the Cash Ratio is 0.92. Considering the valuation of this stock, the price to sales ratio is 43.05, the price to book ratio is 1.11.
Transactions by insiders
Recent insider trading involved Duran Felipe, Chief Financial Officer, that happened on Jan 10 ’25 when 9191.0 shares were purchased. See Remarks, Brenner Martin completed a deal on Jan 10 ’25 to buy 9191.0 shares. Meanwhile, Chief Legal Officer Banjak Marc bought 9191.0 shares on Jan 10 ’25.
